Literature DB >> 32552399

Optical coherence tomography in the evaluation of retinitis pigmentosa.

Jin Kyun Oh1,2, Yan Nuzbrokh1,3, Jose Ronaldo Lima de Carvalho1,4,5, Joseph Ryu1, Stephen H Tsang1,6.   

Abstract

BACKGROUND: Optical coherence tomography (OCT) is a non-invasive imaging test that provides easily obtainable and highly reproducible cross-sectional images of the retina. Improved modalities of the OCT that are capable of providing high quality images of not only the retina, but also the deeper structures and vasculature have been developed, including swept-source OCTs and OCT angiography.
MATERIALS AND METHODS: Review.
RESULTS: The use of OCT in the monitoring of retinitis pigmentosa has been well described and numerous signs of disease progression have been studied. Notably among them are the detection of changes to retinal thickness, the ellipsoid zone, the vasculature on OCT angiography, and cystoid macular edema.
CONCLUSION: In this review, we discuss the multiple applications of OCT as a tool in the monitoring of retinitis pigmentosa and its potential use as an outcome measurement in current and future therapeutic endeavors.

Entities:  

Keywords:  Optical coherence tomography; cystoid macular edema; optical coherence tomography angiography; retinal thickness; retinitis pigmentosa

Mesh:

Year:  2020        PMID: 32552399      PMCID: PMC9362879          DOI: 10.1080/13816810.2020.1780619

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.274


  53 in total

1.  Cystoid macular changes on optical coherence tomography in a patient with maternally inherited diabetes and deafness (MIDD)-associated macular dystrophy.

Authors:  Cynthia X Qian; Kari Branham; Naheed Khan; Steven K Lundy; John R Heckenlively; Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2017-01-31       Impact factor: 1.803

2.  Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.

Authors:  Marsha A Apushkin; Gerald A Fishman; Sandeep Grover; Mark J Janowicz
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

3.  Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.

Authors:  Sandeep Grover; Marsha A Apushkin; Gerald A Fishman
Journal:  Am J Ophthalmol       Date:  2006-03-20       Impact factor: 5.258

4.  Correlation of outer nuclear layer thickness with cone density values in patients with retinitis pigmentosa and healthy subjects.

Authors:  Moreno Menghini; Brandon J Lujan; Shiri Zayit-Soudry; Reema Syed; Travis C Porco; Kristine Bayabo; Joseph Carroll; Austin Roorda; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-16       Impact factor: 4.799

5.  The structure and function of the macula in patients with advanced retinitis pigmentosa.

Authors:  Rita Vámos; Erika Tátrai; János Németh; Graham E Holder; Delia Cabrera DeBuc; Gábor Márk Somfai
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

6.  Quantification of Macular Microvascular Changes in Patients With Retinitis Pigmentosa Using Optical Coherence Tomography Angiography.

Authors:  Daiki Inooka; Shinji Ueno; Taro Kominami; Akira Sayo; Satoshi Okado; Yasuki Ito; Hiroko Terasaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

7.  Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.

Authors:  David G Birch; Kirsten G Locke; Yuquan Wen; Kelly I Locke; Dennis R Hoffman; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

8.  Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa.

Authors:  G A Fishman; L D Gilbert; R G Fiscella; A E Kimura; L M Jampol
Journal:  Arch Ophthalmol       Date:  1989-10

9.  Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography.

Authors:  Donald C Hood; Christine E Lin; Margot A Lazow; Kirsten G Locke; Xian Zhang; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

10.  The dark atrophy with indocyanine green angiography in Stargardt disease.

Authors:  Andrea Giani; Marco Pellegrini; Elisa Carini; Antonio Peroglio Deiro; Ferdinando Bottoni; Giovanni Staurenghi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-26       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.